Back to top

Image: Bigstock

New Strong Buy Stocks for December 13th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

NMI Holdings, Inc. (NMIH - Free Report) : This company that provides private mortgage guaranty insurance services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

NMI Holdings Inc Price and Consensus

 

NMI Holdings Inc Price and Consensus

NMI Holdings Inc price-consensus-chart | NMI Holdings Inc Quote

America's Car-Mart, Inc. (CRMT - Free Report) : This company that operates as an automotive retailer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.

comScore, Inc. (SCOR - Free Report) : This company that operates as an information and analytics company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.

comScore, Inc. Price and Consensus

 

comScore, Inc. Price and Consensus

comScore, Inc. price-consensus-chart | comScore, Inc. Quote

Emmaus Life Sciences, Inc. (EMMA - Free Report) : This company that engages in the discovery, development, and commercialization of treatments and therapies has witnessed the Zacks Consensus Estimate for its current year earnings increasing 83.3% over the last 60 days.

InterXion Holding N.V. : This company that provides carrier and cloud-neutral colocation data center services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.6% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in